Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 9,000 shares at $3.01 ($27K) on 2023-05-24, disclosed to the SEC on 2023-05-24.
Open-market purchase of $27k AVTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.96 | 5,519 | $16K | 60.9% |
| 2 | $3.01 | 3,481 | $10K | 39.1% |
| Total | $2.98 avg | 9,000 | $27K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |